Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2011 Jun 28;123(25):2913-5.
doi: 10.1161/CIRCULATIONAHA.111.034272.

Current capabilities and challenges for optical coherence tomography as a high-impact cardiovascular imaging modality

Editorial

Current capabilities and challenges for optical coherence tomography as a high-impact cardiovascular imaging modality

Mark E Brezinski. Circulation. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1. Lack of correlation in diffuse boundaries and lipid content
This figure is from the initial Circulation publication from 1996. The yellow arrows demonstrate the cap-lipid interface that is diffuse and is covered by a highly scattering cap (yellow reflections in cap). The white arrow, which is also over lipid, identifies a cap with lower scattering and the cap-lipid interface is sharply defined. Both are over the same lipid collection. Finally, the black arrow shows the intimal-elastic layer interface (no lipid present) that is diffuse, with an intima that is highly scattering. In figure 1B, E, and F of the S-J Kang et. al. paper, there are diffuse border plaques, but the caps over them are highly scattering, which is potentially the etiology. The concern is therefore whether the lipid interface is diffuse in some OCT images because of the core composition, as others have previously suggested, or high scattering from the cap, as we have previously suggested. It is possible that highly scattering caps correlate with lipid plaques, but it is also possible that this scattering is the etiology for the variations in sensitivity and specificity. As clinical studies are now being performed in large numbers due to the availability of the technology, like the paper in this issue, OCT’s lipid characterizing ability needs to be more firmly established.

Comment on

References

    1. Kang SJ, Mintz GS, Akasaka T, et al. Optical Coherent Tomographic Analysis of In-stent Neo-atherosclerosis after Drug-Eluting Stent Implantation. (CIRCULATIONAHA/2010/988436) - PubMed
    1. Brezinski ME. Optical Coherence Tomography: Principle and Practice. Burlington: Academic Press; 2006.
    1. Brezinski ME, Tearney GJ, Bouma BE, Izatt JA, Hee MR, Swanson EA, Southern JF, Fujimoto JG. Optical coherence tomography for optical biopsy - properties and demonstration of vascular pathology. Circulation. 1996;93:1206–1213. - PubMed
    1. St. Jude Medical, St. Paul Minnesota. http://www.sjmprofessional.com /Products/US/Imaging-Diagnostics/OCT-Tech....
    1. Tanigawa J, Barlis P, Dimopoulos K, Dalby M, Moore P, Di Mario C. The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography. International Journal Of Cardiology. 2009;134:180–188. - PubMed

MeSH terms